We speculate that CAR-derived potent antigen-specific signals, combined with the complex immune synapse formed during CAR-T/tumor cell interactions, collectively reprogram CD8+ T-cell responsiveness and provide essential synergistic signaling. The gene discussed is CD8A; the disease is neoplasm.